Wake-Up Call: Lessons Learned from Poland must Reaffirm TB as an EU Health Priority 21/03/2024 Krzysztof Herboczek & Joanna Ladomirska Over the last century, Europe – including Northern, Western, Southern and Central European countries – made remarkable progress in the near elimination of tuberculosis (TB) due to improved socio-economic conditions and advancements in research and development. However, a recent surge of TB in Europe, coupled with lack of structural preparedness within many European Union (EU) […] Continue reading -> TB Vaccine Phase 3 Trial Launched, as WHO Makes Case for Investing in Screening and Prevention 20/03/2024 Disha Shetty A Phase 3 trial of a tuberculosis vaccine candidate has been launched in South Africa, according to the Bill & Melinda Gates Medical Research Institute (Gates MRI). The candidate vaccine – referred to as M72/AS01E – “could potentially become the first vaccine to help prevent pulmonary TB in adolescents and adults, the most common form […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Alzheimer’s Experts Review Progress and Challenges in a ‘Transformative Moment’ 01/03/2024 Sophia Samantaroy WASHINGTON, DC – When US Senator Amy Klobuchar’s father, the late Jim Klobuchar, was diagnosed with Alzheimer’s disease, the noted Minnesota newspaper columnist gradually stopped recognizing her – although he retained “a kind of savoir faire” to the very end with words, jokes and storytelling based on the decades of “lines enmeshed in his memory,” […] Continue reading -> India Pushes Back To Protect Patient Access to Generic Medicines 15/02/2024 Disha Shetty PUNE, INDIA – Commerce minister Sunil Barthwal has clarified that India will not sign a new trade agreement with the European Free Trade Association (EFTA) that would limit access by the country’s thriving generic medicine industry to new drug formulations for critical diseases. India is currently negotiating a new trade deal with the EFTA, which […] Continue reading -> WHO Issues First-Ever List of Antimicrobials with Category “For Use in Humans Only” 13/02/2024 Sophia Samantaroy The WHO has released a first-ever list of 21 antimicrobials earmarked as “authorized for use in humans only” – a first for the organization in its efforts to protect overuse and abuse of critical first-line drugs that need to be protected by overuse in animal and plant health sectors – and consequent antimicrobial resistance (AMR). […] Continue reading -> Charting a New Course to Hepatitis Elimination in Pakistan 09/02/2024 Nida Ali Approximately 10 million Pakistanis are living with hepatitis C (HCV) with three people dying of HCV- related causes every minute – and this in the case of a disease that is now largely curable with treatment. Hepatitis B Virus (HBV) also poses major public health burden on the country’s health system with an estimated 4 […] Continue reading -> EXCLUSIVE: Reject Drug Procurement Secrecy, Civil Society Urges ‘Big Five’ Buyers 07/02/2024 Kerry Cullinan Over 50 civil society groups have written to the leaders of the world’s biggest medicine procurement programmes urging them to reject “secrecy clauses” in their agreements with pharmaceutical companies. The letter, which has been shared exclusively with Health Policy Watch, was sent to the heads of UNICEF, the Pan American Health Organization (PAHO), vaccine alliance […] Continue reading -> Soumya Swaminathan Returns to International Arena to Fight Air Pollution 01/02/2024 Chetan Bhattacharji Dr Soumya Swaminathan is returning to the international stage after leaving the World Health Organization (WHO) in late 2022, just as the world was recovering from the COVID-19 pandemic. She became the agency’s first Chief Scientist just before the pandemic, a position that propelled her to become a widely-known global voice for WHO, analyzing and […] Continue reading -> The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> Posts navigation Older postsNewer posts
TB Vaccine Phase 3 Trial Launched, as WHO Makes Case for Investing in Screening and Prevention 20/03/2024 Disha Shetty A Phase 3 trial of a tuberculosis vaccine candidate has been launched in South Africa, according to the Bill & Melinda Gates Medical Research Institute (Gates MRI). The candidate vaccine – referred to as M72/AS01E – “could potentially become the first vaccine to help prevent pulmonary TB in adolescents and adults, the most common form […] Continue reading -> WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Alzheimer’s Experts Review Progress and Challenges in a ‘Transformative Moment’ 01/03/2024 Sophia Samantaroy WASHINGTON, DC – When US Senator Amy Klobuchar’s father, the late Jim Klobuchar, was diagnosed with Alzheimer’s disease, the noted Minnesota newspaper columnist gradually stopped recognizing her – although he retained “a kind of savoir faire” to the very end with words, jokes and storytelling based on the decades of “lines enmeshed in his memory,” […] Continue reading -> India Pushes Back To Protect Patient Access to Generic Medicines 15/02/2024 Disha Shetty PUNE, INDIA – Commerce minister Sunil Barthwal has clarified that India will not sign a new trade agreement with the European Free Trade Association (EFTA) that would limit access by the country’s thriving generic medicine industry to new drug formulations for critical diseases. India is currently negotiating a new trade deal with the EFTA, which […] Continue reading -> WHO Issues First-Ever List of Antimicrobials with Category “For Use in Humans Only” 13/02/2024 Sophia Samantaroy The WHO has released a first-ever list of 21 antimicrobials earmarked as “authorized for use in humans only” – a first for the organization in its efforts to protect overuse and abuse of critical first-line drugs that need to be protected by overuse in animal and plant health sectors – and consequent antimicrobial resistance (AMR). […] Continue reading -> Charting a New Course to Hepatitis Elimination in Pakistan 09/02/2024 Nida Ali Approximately 10 million Pakistanis are living with hepatitis C (HCV) with three people dying of HCV- related causes every minute – and this in the case of a disease that is now largely curable with treatment. Hepatitis B Virus (HBV) also poses major public health burden on the country’s health system with an estimated 4 […] Continue reading -> EXCLUSIVE: Reject Drug Procurement Secrecy, Civil Society Urges ‘Big Five’ Buyers 07/02/2024 Kerry Cullinan Over 50 civil society groups have written to the leaders of the world’s biggest medicine procurement programmes urging them to reject “secrecy clauses” in their agreements with pharmaceutical companies. The letter, which has been shared exclusively with Health Policy Watch, was sent to the heads of UNICEF, the Pan American Health Organization (PAHO), vaccine alliance […] Continue reading -> Soumya Swaminathan Returns to International Arena to Fight Air Pollution 01/02/2024 Chetan Bhattacharji Dr Soumya Swaminathan is returning to the international stage after leaving the World Health Organization (WHO) in late 2022, just as the world was recovering from the COVID-19 pandemic. She became the agency’s first Chief Scientist just before the pandemic, a position that propelled her to become a widely-known global voice for WHO, analyzing and […] Continue reading -> The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> Posts navigation Older postsNewer posts
WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows Promise With TB Treatment 14/03/2024 Kerry Cullinan The World Health Organization (WHO) recently reported drug resistance to the world’s gold-standard antiretroviral medicine, dolutegravir “exceeding levels observed in clinical trials” – with resistance ranging from 3.9% to 19.6%. This was potentially very bad news as dolutegravir has been the recommended first- and second-line HIV treatment for all population groups since 2018 – but […] Continue reading -> Alzheimer’s Experts Review Progress and Challenges in a ‘Transformative Moment’ 01/03/2024 Sophia Samantaroy WASHINGTON, DC – When US Senator Amy Klobuchar’s father, the late Jim Klobuchar, was diagnosed with Alzheimer’s disease, the noted Minnesota newspaper columnist gradually stopped recognizing her – although he retained “a kind of savoir faire” to the very end with words, jokes and storytelling based on the decades of “lines enmeshed in his memory,” […] Continue reading -> India Pushes Back To Protect Patient Access to Generic Medicines 15/02/2024 Disha Shetty PUNE, INDIA – Commerce minister Sunil Barthwal has clarified that India will not sign a new trade agreement with the European Free Trade Association (EFTA) that would limit access by the country’s thriving generic medicine industry to new drug formulations for critical diseases. India is currently negotiating a new trade deal with the EFTA, which […] Continue reading -> WHO Issues First-Ever List of Antimicrobials with Category “For Use in Humans Only” 13/02/2024 Sophia Samantaroy The WHO has released a first-ever list of 21 antimicrobials earmarked as “authorized for use in humans only” – a first for the organization in its efforts to protect overuse and abuse of critical first-line drugs that need to be protected by overuse in animal and plant health sectors – and consequent antimicrobial resistance (AMR). […] Continue reading -> Charting a New Course to Hepatitis Elimination in Pakistan 09/02/2024 Nida Ali Approximately 10 million Pakistanis are living with hepatitis C (HCV) with three people dying of HCV- related causes every minute – and this in the case of a disease that is now largely curable with treatment. Hepatitis B Virus (HBV) also poses major public health burden on the country’s health system with an estimated 4 […] Continue reading -> EXCLUSIVE: Reject Drug Procurement Secrecy, Civil Society Urges ‘Big Five’ Buyers 07/02/2024 Kerry Cullinan Over 50 civil society groups have written to the leaders of the world’s biggest medicine procurement programmes urging them to reject “secrecy clauses” in their agreements with pharmaceutical companies. The letter, which has been shared exclusively with Health Policy Watch, was sent to the heads of UNICEF, the Pan American Health Organization (PAHO), vaccine alliance […] Continue reading -> Soumya Swaminathan Returns to International Arena to Fight Air Pollution 01/02/2024 Chetan Bhattacharji Dr Soumya Swaminathan is returning to the international stage after leaving the World Health Organization (WHO) in late 2022, just as the world was recovering from the COVID-19 pandemic. She became the agency’s first Chief Scientist just before the pandemic, a position that propelled her to become a widely-known global voice for WHO, analyzing and […] Continue reading -> The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> Posts navigation Older postsNewer posts
Alzheimer’s Experts Review Progress and Challenges in a ‘Transformative Moment’ 01/03/2024 Sophia Samantaroy WASHINGTON, DC – When US Senator Amy Klobuchar’s father, the late Jim Klobuchar, was diagnosed with Alzheimer’s disease, the noted Minnesota newspaper columnist gradually stopped recognizing her – although he retained “a kind of savoir faire” to the very end with words, jokes and storytelling based on the decades of “lines enmeshed in his memory,” […] Continue reading -> India Pushes Back To Protect Patient Access to Generic Medicines 15/02/2024 Disha Shetty PUNE, INDIA – Commerce minister Sunil Barthwal has clarified that India will not sign a new trade agreement with the European Free Trade Association (EFTA) that would limit access by the country’s thriving generic medicine industry to new drug formulations for critical diseases. India is currently negotiating a new trade deal with the EFTA, which […] Continue reading -> WHO Issues First-Ever List of Antimicrobials with Category “For Use in Humans Only” 13/02/2024 Sophia Samantaroy The WHO has released a first-ever list of 21 antimicrobials earmarked as “authorized for use in humans only” – a first for the organization in its efforts to protect overuse and abuse of critical first-line drugs that need to be protected by overuse in animal and plant health sectors – and consequent antimicrobial resistance (AMR). […] Continue reading -> Charting a New Course to Hepatitis Elimination in Pakistan 09/02/2024 Nida Ali Approximately 10 million Pakistanis are living with hepatitis C (HCV) with three people dying of HCV- related causes every minute – and this in the case of a disease that is now largely curable with treatment. Hepatitis B Virus (HBV) also poses major public health burden on the country’s health system with an estimated 4 […] Continue reading -> EXCLUSIVE: Reject Drug Procurement Secrecy, Civil Society Urges ‘Big Five’ Buyers 07/02/2024 Kerry Cullinan Over 50 civil society groups have written to the leaders of the world’s biggest medicine procurement programmes urging them to reject “secrecy clauses” in their agreements with pharmaceutical companies. The letter, which has been shared exclusively with Health Policy Watch, was sent to the heads of UNICEF, the Pan American Health Organization (PAHO), vaccine alliance […] Continue reading -> Soumya Swaminathan Returns to International Arena to Fight Air Pollution 01/02/2024 Chetan Bhattacharji Dr Soumya Swaminathan is returning to the international stage after leaving the World Health Organization (WHO) in late 2022, just as the world was recovering from the COVID-19 pandemic. She became the agency’s first Chief Scientist just before the pandemic, a position that propelled her to become a widely-known global voice for WHO, analyzing and […] Continue reading -> The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> Posts navigation Older postsNewer posts
India Pushes Back To Protect Patient Access to Generic Medicines 15/02/2024 Disha Shetty PUNE, INDIA – Commerce minister Sunil Barthwal has clarified that India will not sign a new trade agreement with the European Free Trade Association (EFTA) that would limit access by the country’s thriving generic medicine industry to new drug formulations for critical diseases. India is currently negotiating a new trade deal with the EFTA, which […] Continue reading -> WHO Issues First-Ever List of Antimicrobials with Category “For Use in Humans Only” 13/02/2024 Sophia Samantaroy The WHO has released a first-ever list of 21 antimicrobials earmarked as “authorized for use in humans only” – a first for the organization in its efforts to protect overuse and abuse of critical first-line drugs that need to be protected by overuse in animal and plant health sectors – and consequent antimicrobial resistance (AMR). […] Continue reading -> Charting a New Course to Hepatitis Elimination in Pakistan 09/02/2024 Nida Ali Approximately 10 million Pakistanis are living with hepatitis C (HCV) with three people dying of HCV- related causes every minute – and this in the case of a disease that is now largely curable with treatment. Hepatitis B Virus (HBV) also poses major public health burden on the country’s health system with an estimated 4 […] Continue reading -> EXCLUSIVE: Reject Drug Procurement Secrecy, Civil Society Urges ‘Big Five’ Buyers 07/02/2024 Kerry Cullinan Over 50 civil society groups have written to the leaders of the world’s biggest medicine procurement programmes urging them to reject “secrecy clauses” in their agreements with pharmaceutical companies. The letter, which has been shared exclusively with Health Policy Watch, was sent to the heads of UNICEF, the Pan American Health Organization (PAHO), vaccine alliance […] Continue reading -> Soumya Swaminathan Returns to International Arena to Fight Air Pollution 01/02/2024 Chetan Bhattacharji Dr Soumya Swaminathan is returning to the international stage after leaving the World Health Organization (WHO) in late 2022, just as the world was recovering from the COVID-19 pandemic. She became the agency’s first Chief Scientist just before the pandemic, a position that propelled her to become a widely-known global voice for WHO, analyzing and […] Continue reading -> The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> Posts navigation Older postsNewer posts
WHO Issues First-Ever List of Antimicrobials with Category “For Use in Humans Only” 13/02/2024 Sophia Samantaroy The WHO has released a first-ever list of 21 antimicrobials earmarked as “authorized for use in humans only” – a first for the organization in its efforts to protect overuse and abuse of critical first-line drugs that need to be protected by overuse in animal and plant health sectors – and consequent antimicrobial resistance (AMR). […] Continue reading -> Charting a New Course to Hepatitis Elimination in Pakistan 09/02/2024 Nida Ali Approximately 10 million Pakistanis are living with hepatitis C (HCV) with three people dying of HCV- related causes every minute – and this in the case of a disease that is now largely curable with treatment. Hepatitis B Virus (HBV) also poses major public health burden on the country’s health system with an estimated 4 […] Continue reading -> EXCLUSIVE: Reject Drug Procurement Secrecy, Civil Society Urges ‘Big Five’ Buyers 07/02/2024 Kerry Cullinan Over 50 civil society groups have written to the leaders of the world’s biggest medicine procurement programmes urging them to reject “secrecy clauses” in their agreements with pharmaceutical companies. The letter, which has been shared exclusively with Health Policy Watch, was sent to the heads of UNICEF, the Pan American Health Organization (PAHO), vaccine alliance […] Continue reading -> Soumya Swaminathan Returns to International Arena to Fight Air Pollution 01/02/2024 Chetan Bhattacharji Dr Soumya Swaminathan is returning to the international stage after leaving the World Health Organization (WHO) in late 2022, just as the world was recovering from the COVID-19 pandemic. She became the agency’s first Chief Scientist just before the pandemic, a position that propelled her to become a widely-known global voice for WHO, analyzing and […] Continue reading -> The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> Posts navigation Older postsNewer posts
Charting a New Course to Hepatitis Elimination in Pakistan 09/02/2024 Nida Ali Approximately 10 million Pakistanis are living with hepatitis C (HCV) with three people dying of HCV- related causes every minute – and this in the case of a disease that is now largely curable with treatment. Hepatitis B Virus (HBV) also poses major public health burden on the country’s health system with an estimated 4 […] Continue reading -> EXCLUSIVE: Reject Drug Procurement Secrecy, Civil Society Urges ‘Big Five’ Buyers 07/02/2024 Kerry Cullinan Over 50 civil society groups have written to the leaders of the world’s biggest medicine procurement programmes urging them to reject “secrecy clauses” in their agreements with pharmaceutical companies. The letter, which has been shared exclusively with Health Policy Watch, was sent to the heads of UNICEF, the Pan American Health Organization (PAHO), vaccine alliance […] Continue reading -> Soumya Swaminathan Returns to International Arena to Fight Air Pollution 01/02/2024 Chetan Bhattacharji Dr Soumya Swaminathan is returning to the international stage after leaving the World Health Organization (WHO) in late 2022, just as the world was recovering from the COVID-19 pandemic. She became the agency’s first Chief Scientist just before the pandemic, a position that propelled her to become a widely-known global voice for WHO, analyzing and […] Continue reading -> The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> Posts navigation Older postsNewer posts
EXCLUSIVE: Reject Drug Procurement Secrecy, Civil Society Urges ‘Big Five’ Buyers 07/02/2024 Kerry Cullinan Over 50 civil society groups have written to the leaders of the world’s biggest medicine procurement programmes urging them to reject “secrecy clauses” in their agreements with pharmaceutical companies. The letter, which has been shared exclusively with Health Policy Watch, was sent to the heads of UNICEF, the Pan American Health Organization (PAHO), vaccine alliance […] Continue reading -> Soumya Swaminathan Returns to International Arena to Fight Air Pollution 01/02/2024 Chetan Bhattacharji Dr Soumya Swaminathan is returning to the international stage after leaving the World Health Organization (WHO) in late 2022, just as the world was recovering from the COVID-19 pandemic. She became the agency’s first Chief Scientist just before the pandemic, a position that propelled her to become a widely-known global voice for WHO, analyzing and […] Continue reading -> The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> Posts navigation Older postsNewer posts
Soumya Swaminathan Returns to International Arena to Fight Air Pollution 01/02/2024 Chetan Bhattacharji Dr Soumya Swaminathan is returning to the international stage after leaving the World Health Organization (WHO) in late 2022, just as the world was recovering from the COVID-19 pandemic. She became the agency’s first Chief Scientist just before the pandemic, a position that propelled her to become a widely-known global voice for WHO, analyzing and […] Continue reading -> The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> Posts navigation Older postsNewer posts
The Right to Health in Humanitarian Crises Needs to Encompass Non-Communicable Diseases 01/02/2024 Micaela Serafini, Katie Dain & Nicolai Haugaard The United Nations estimates that 363 million people are currently impacted by humanitarian crises driven by increasing fragility and conflict, the climate crisis and widening inequality. Around 108.4 million people were forced to flee their homes in 2022, meaning one in every 74 persons globally. Humanitarian crises, such as those occurring in Ukraine, Gaza, Libya, […] Continue reading -> Posts navigation Older postsNewer posts